TinnitX

Company Overview

Snapshot

Founded in July 2016 by Michael Kardosh, TinnitX operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on the development of its digital therapeutic device.

Business overview

TinnitX is a Health Tech & Life Sciences company developing a digital therapeutic device designed to mask tinnitus. Its core technology involves applying a personalized masking tone via a comfortable bone conduction sticker, specifically for use during sleep. The generated tone is patient-specific, dynamic, and responsive to biofeedback from wearable devices and data from other users with similar tinnitus characteristics. TinnitX operates within the Digital Healthcare and Medical Devices sectors, targeting patients globally with its B2B business model.

Company Intelligence Q&A

What is TinnitX's primary focus?

TinnitX is focused on developing a digital therapeutic device for masking tinnitus through bone conduction audio and personally generated tones.

When was TinnitX founded?

TinnitX was founded in July 2016 by Michael Kardosh.

What is the current stage of TinnitX's product development?

TinnitX's product is currently in the Research & Development (R&D) stage, focusing on developing its digital therapeutic device.

What technology does TinnitX utilize for its device?

TinnitX utilizes bone conduction audio and a personalized, dynamic masking tone that responds to biofeedback from wearable devices.

Which markets does TinnitX target?

TinnitX targets the global market with its medical device, focusing on patients suffering from tinnitus.